- Home
- NTRP vs COCP Comparison
NTRP vs COCP Comparison
Compare NTRP & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRP
- COCP
- Stock Information
- Founded
- NTRP 1985
- COCP 2006
- Country
- NTRP United States
- COCP United States
- Employees
- NTRP N/A
- COCP N/A
- Industry
- NTRP
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- NTRP
- COCP Health Care
- Exchange
- NTRP NYSE
- COCP Nasdaq
- Market Cap
- NTRP 12.7M
- COCP 15.7M
- IPO Year
- NTRP N/A
- COCP N/A
- Fundamental
- Price
- NTRP $2.05
- COCP $1.71
- Analyst Decision
- NTRP Hold
- COCP Strong Buy
- Analyst Count
- NTRP 1
- COCP 1
- Target Price
- NTRP $5.00
- COCP $7.00
- AVG Volume (30 Days)
- NTRP 295.1K
- COCP 20.7K
- Earning Date
- NTRP 06-10-2025
- COCP 05-15-2025
- Dividend Yield
- NTRP N/A
- COCP N/A
- EPS Growth
- NTRP N/A
- COCP N/A
- EPS
- NTRP N/A
- COCP N/A
- Revenue
- NTRP $501,422.00
- COCP N/A
- Revenue This Year
- NTRP $354.28
- COCP N/A
- Revenue Next Year
- NTRP $536.37
- COCP N/A
- P/E Ratio
- NTRP N/A
- COCP N/A
- Revenue Growth
- NTRP 186.93
- COCP N/A
- 52 Week Low
- NTRP $1.39
- COCP $1.12
- 52 Week High
- NTRP $8.50
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- NTRP 40.18
- COCP 63.96
- Support Level
- NTRP $1.72
- COCP $1.40
- Resistance Level
- NTRP $2.21
- COCP $1.62
- Average True Range (ATR)
- NTRP 0.23
- COCP 0.16
- MACD
- NTRP 0.06
- COCP 0.02
- Stochastic Oscillator
- NTRP 42.86
- COCP 79.49
About NTRP NEXTTRIP INC
NextTrip Inc is a technology-driven platform delivering travel booking and travel media solutions. It provides individual and group travelers with vacations to popular and sought-after destinations in Mexico, the Caribbean, and across the world. NextTrip Media platform - Travel Magazine offers a social media platform for viewers to explore, educate, and share with friends their bucket list travel. The company is also launching an end-to-end content ecosystem that uses AI-assisted travel planning capturing advertising, building brand awareness, rewarding loyalty, and driving bookings.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).